Last reviewed · How we verify
NCT05838911: NEMS for COPD
Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease
NA trial testing Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES) in Pulmonary Rehabilitation in 60 participants. Completed in 13 August 2023.
13 August 2023
Quick facts
| Lead sponsor | Beni-Suef University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 2 April 2023 |
| Primary completion | 13 August 2023 |
| Estimated completion | 13 August 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)
- Control Group Chest physical therapy
Conditions studied
- Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
- Chronic Obstructive Lung Disease — all drugs for Chronic Obstructive Lung Disease →
- Neuromuscular Electrical Stimulation — all drugs for Neuromuscular Electrical Stimulation →
- Pulmonary Function (FEV1/FVC) — all drugs for Pulmonary Function (FEV1/FVC) →
Sponsor
Beni-Suef University
Who can join
Adults 65 to 75, any sex, with Pulmonary Rehabilitation or Chronic Obstructive Lung Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training. Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscles strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05838911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Rehabilitation
Currently open trials in the same condition.
- NCT07430943 — Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation · NA · recruiting
- NCT07185178 — Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS · NA · recruiting
- NCT07061444 — Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients · NA · recruiting
- NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
- NCT07195838 — Mindful-Breath for People With COPD · NA · recruiting
Other Beni-Suef University trials
Trials by the same sponsor.
- NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
- NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
- NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
- NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05838911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
- Last refreshed: 30 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing